Abvc Biopharma (ABVC) EBT Margin (2009 - 2026)
Abvc Biopharma's EBT Margin came in at -1847.54% for Q2 2026.
Powered by 
Analysis
Abvc Biopharma (ABVC) EBT Margin (2009 - 2026) Analysis & Trends
For FY2025, Abvc Biopharma's EBT Margin was -26284.04%, down 25230.33 percentage points from FY2024.
- EBT Margin carries a five-year change of -24045.34 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -1053.71% in FY2024 (+4210.90 pp), -5264.61% in FY2023 (-3664.80 pp), -1599.80% in FY2022 (+1551.10 pp) and -3150.91% in FY2021 (-912.20 pp).
- The Q2 2026 figure represents the highest quarterly EBT Margin since Q3 2024.
- The fastest year-over-year change in EBT Margin over five years came in Q2 2024 (a gain of 35572.50 percentage points), and the weakest in Q1 2024 (a drop of 241480.85 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 20.41% |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,847.54% |
| Dec 31, 2024 | -40,515.11% |
| Sep 30, 2024 | -125.12% |
| Jun 30, 2024 | -988.81% |
| Mar 31, 2024 | -242,959.92% |
| Dec 31, 2023 | -24,249.38% |
| Sep 30, 2023 | -21,210.52% |
| Jun 30, 2023 | -36,561.30% |
| Mar 31, 2023 | -1,479.07% |
| Dec 31, 2022 | -600.69% |
| Sep 30, 2022 | -8,924.51% |
| Jun 30, 2022 | -648.78% |
| Mar 31, 2022 | -24,062.67% |
| Sep 30, 2021 | -1,981.75% |
| Jun 30, 2021 | -6,719.00% |
| Mar 31, 2021 | -473.63% |
| Dec 31, 2020 | -8,128.79% |
| Sep 30, 2020 | -1,883.00% |
| Jun 30, 2020 | -985.68% |
| Mar 31, 2020 | -1,713.29% |
API Access
Abvc Biopharma EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();